Literature DB >> 2582568

Epidural anaesthesia for caesarean section in patients with active recurrent genital herpes simplex infections: a retrospective review.

E T Crosby1, S H Halpern, S H Rolbin.   

Abstract

The safety of epidural anaesthesia in patients with active, recurrent genital herpes simplex (HSV) infections is controversial. We reviewed the six-year experience of the use of epidural anaesthesia in this patient population in two institutions. Eighty-nine parturients with active genital HSV were administered epidural anaesthesia for Caesarean section. No patient suffered an adverse outcome related to either the anaesthetic or the virus. The theoretical risks of regional anaesthesia in the parturient with active herpes genitalis are reviewed. We conclude from available data that the risk of an adverse outcome is small and does not contraindicate the use of epidural anaesthesia in patients with recurrent infection.

Entities:  

Mesh:

Year:  1989        PMID: 2582568     DOI: 10.1007/BF03005425

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  Genital herpes simplex virus infections complicating pregnancy. Natural history and peripartum management.

Authors:  Z A Brown; S Berry; L A Vontver
Journal:  J Reprod Med       Date:  1986-05       Impact factor: 0.142

2.  Anesthesia for cesarean section in patients with genital herpes infections: a retrospective study.

Authors:  S Ramanathan; R Sheth; H Turndorf
Journal:  Anesthesiology       Date:  1986-06       Impact factor: 7.892

3.  Uncertainty as to the acceptance or rejection of the presence of an effect in relation to the number of observations in an experiment.

Authors:  C L Rümke
Journal:  Triangle       Date:  1968

4.  Fatal herpetic hepatitis in pregnancy.

Authors:  R A Wertheim; B J Brooks; F H Rodriguez; H R Lesesne; J C Jennette
Journal:  Obstet Gynecol       Date:  1983-09       Impact factor: 7.661

Review 5.  Pregnancy-associated depression of cell-mediated immunity.

Authors:  E D Weinberg
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

6.  Epidural analgesia in the presence of herpes simplex virus (type 2) infection.

Authors:  R S Ravindran; C D Gupta; C A Stoops
Journal:  Anesth Analg       Date:  1982-08       Impact factor: 5.108

7.  Herpes simplex infection at term. What to do with mother, newborn, and nursery personnel.

Authors:  S Kibrick
Journal:  JAMA       Date:  1980-01-11       Impact factor: 56.272

8.  Disseminated herpesvirus infection. Association with primary genital herpes in pregnancy.

Authors:  E J Young; A P Killam; J F Greene
Journal:  JAMA       Date:  1976-06-21       Impact factor: 56.272

9.  Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery.

Authors:  A M Arvin; P A Hensleigh; C G Prober; D S Au; L L Yasukawa; A E Wittek; P E Palumbo; S G Paryani; A S Yeager
Journal:  N Engl J Med       Date:  1986-09-25       Impact factor: 91.245

Review 10.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

View more
  4 in total

1.  The obstetrical anaesthesia assessment clinic: a review of six years experience.

Authors:  O P Rosaeg; R W Yarnell; M P Lindsay
Journal:  Can J Anaesth       Date:  1993-04       Impact factor: 5.063

Review 2.  Neuraxial Regional Anaesthesia in Patients with Active Infection and Sepsis: A Clinical Narrative Review.

Authors:  Ana María Gimeno; Carlos Luis Errando
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-02-01

Review 3.  [Regional anesthesia in patients with pre-existing infections or immunosuppression].

Authors:  F List; P Kessler; T Volk
Journal:  Anaesthesist       Date:  2013-03       Impact factor: 1.041

4.  Neuraxial labor analgesia in an obese parturient with influenza A H1N1.

Authors:  A I Lee; M J Hoffman; N N Allen; J T Sullivan
Journal:  Int J Obstet Anesth       Date:  2010-03-02       Impact factor: 2.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.